-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MGlirXB2qJJfgmdyhyfJowYiod8WK8l8F5u2WM9WO05M8HNPZ3MfIJaJ/3gxcnrN AL9CEk2mdZZl+++Zx2ZLTQ== /in/edgar/work/0000906344-00-000072/0000906344-00-000072.txt : 20001116 0000906344-00-000072.hdr.sgml : 20001116 ACCESSION NUMBER: 0000906344-00-000072 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20001115 GROUP MEMBERS: YAMANOUCHI GROUP HOLDING, INC. GROUP MEMBERS: YAMANOUCHI PHARMACEUTICAL CO LTD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SHIRE PHARMACEUTICALS GROUP PLC CENTRAL INDEX KEY: 0000936402 STANDARD INDUSTRIAL CLASSIFICATION: [2834 ] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-55755 FILM NUMBER: 770186 BUSINESS ADDRESS: STREET 1: EAST ANTON ANDOVER STREET 2: HAMPSHIRE ENGLAND CITY: ENGLAND SP10 5RG STATE: X0 BUSINESS PHONE: 1264333455 MAIL ADDRESS: STREET 1: EAST ANTON ANDOVER STREET 2: HAMPSHIRE ENGLAND CITY: ENGLAND SP10 5RG FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: YAMANOUCHI PHARMACEUTICAL CO LTD CENTRAL INDEX KEY: 0000905462 STANDARD INDUSTRIAL CLASSIFICATION: [ ] FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 311 NILHONBASHI HONCHO 2 CHOME STREET 2: CHUO-KU TOKOYO 103 CITY: JAPAN MAIL ADDRESS: STREET 1: 311 NIHONBASHI HONCHO 2 CHOME STREET 2: CHUO-KU TOKYO CITY: JAPAN STATE: M0 SC 13G/A 1 0001.txt AMENDMENT NO. 1 TO SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102). INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 1) SHIRE PHARMACEUTICALS GROUP plc ------------------------------- (Name of Issuer) Ordinary Shares, nominal value 5p --------------------------------- (Title of Class of Securities) 82481R106* ---------- (CUSIP Number) September 29, 2000 ------------------ (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ ] Rule 13d-1(b) [x] Rule 13d-1(c) [ ] Rule 13d-1(d) *The CUSIP number provided is assigned the American Depository Shares ("ADSs") representing the Ordinary Shares of the Issuer. The positions reported by the Reporting Persons were held in the form of ADSs. CUSIP No. 82481R106 SCHEDULE 13G Page 2 of 4 1 Name Of Reporting Person YAMANOUCHI PHARMACEUTICAL CO., LTD. IRS Identification No. Of Above Person 13-2971791 2 Check The Appropriate Box If A Member Of A Group (a) [x] (b) [ ] 3 SEC USE ONLY 4 Citizenship Or Place Of Organization Japan NUMBER OF 5 Sole Voting Power -0- SHARES BENEFICIALLY 6 Shared Voting Power -0- OWNED BY EACH 7 Sole Dispositive Power -0- REPORTING PERSON WITH 8 Shared Dispositive Power -0- 9 Aggregate Amount Beneficially Owned By Each Reporting Person -0- 10 Check Box If The Aggregate Amount In Row (9) Excludes Certain Shares [ ] 11 Percent Of Class Represented By Amount In Row 9 -0- 12 Type Of Reporting Person HC CUSIP No. 82481R106 SCHEDULE 13G Page 3 of 4 1 Name Of Reporting Person YAMANOUCHI GROUP HOLDING, INC. IRS Identification No. Of Above Person 94-3091443 2 Check The Appropriate Box If A Member Of A Group (a) [x] (b) [ ] 3 SEC USE ONLY 4 Citizenship Or Place Of Organization Delaware NUMBER OF 5 Sole Voting Power -0- SHARES BENEFICIALLY 6 Shared Voting Power -0- OWNED BY EACH REPORTING 7 Sole Dispositive Power -0- PERSON WITH 8 Shared Dispositive Power -0- 9 Aggregate Amount Beneficially Owned By Each Reporting Person -0- 10 Check Box If The Aggregate Amount In Row (9) Excludes Certain Shares* [ ] 11 Percent Of Class Represented By Amount In Row 9 -0- 12 Type Of Reporting Person CO CUSIP No. 82481R106 SCHEDULE 13G Page 4 of 4 Item 4. Ownership. On September 29, 2000, Yamanouchi Group Holding Inc. ("YGH") completed the sale of all of the 5,263,902 American Depositary Shares ("ADSs") of Shire Pharmaceuticals Group plc (representing 15,791,706 Ordinary Shares) that were previously reported as being beneficially owned by YGH and its parent corporation, Yamanouchi Pharmaceutical Co., LTD, ("YPCL"). Accordingly, YGH and YPCL no longer have any beneficial ownership of ADSs or Ordinary Shares of Shire Pharmaceuticals Group plc. Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5% of the class of securities, check the following [x]. Signature After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct. DATED: November 7, 2000. YAMANOUCHI PHARMACEUTICAL CO., LTD. By: /s/ Kaoru Kimura __________________________ Name: Kaoru Kimura Title: Managing Director YAMANOUCHI GROUP HOLDING INC. By: /s/ Kaoru Kimura __________________________ Name: Kaoru Kimura Title: Chief Executive Officer -----END PRIVACY-ENHANCED MESSAGE-----